Skip to main content
Clinical Trials/PACTR202103893112947
PACTR202103893112947
Not yet recruiting
Phase 4

Pilot study evaluating the effect of pharmacogenetics on warfarin dosing and shortening the time to a therapeutic International Normalised Ratio

Ilhaam Fredericks0 sites60 target enrollmentFebruary 27, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Ilhaam Fredericks
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 27, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ilhaam Fredericks

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years old
  • Patients who require warfarin anticoagulation as part of standard of care

Exclusion Criteria

  • Patients who do not have informed consent
  • Patients with mechanical heart valves
  • Patients who were anticoagulated with warfarin in the last 30 days
  • Patients with liver failure

Outcomes

Primary Outcomes

Not specified

Similar Trials